Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Cortes JE et al. Leukemia, July 2026 (epub ahead of print) - open access publication

• Share
• Tweet
• Share
• Share